Department of Immunology, School of Basic Medical Sciences, Xinjiang Medical University, Urumqi, China.
Center for Reproductive Medicine, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
Front Endocrinol (Lausanne). 2024 Mar 5;15:1334599. doi: 10.3389/fendo.2024.1334599. eCollection 2024.
The inability of patients with recurrent implantation failure (RIF) to achieve pregnancy and a live birth after multiple high-quality embryo transfer treatments has been recognized as a major obstacle to successful application of artificial reproductive technologies. The objective of this study was to establish and validate a nomogram for prediction of subsequent first-cycle live births to guide clinical practice in patients diagnosed with RIF.
A total of 538 patients who underwent fertilization/intracytoplasmic sperm injection treatment and were first diagnosed with RIF at the Reproductive Center of the First Affiliated Hospital of Xinjiang Medical University between January 2017 and December 2020 were enrolled. The patients were randomly divided into a training cohort (n=408) and a validation set (n=175) in a ratio of 7:3. A nomogram model was constructed using the training set based on the results of univariate and multivariate logistic regression analyses and validated in the validation set.
Age, body mass index, duration of RIF, endometrial thickness, type of embryo transferred, and number of previous biochemical pregnancies were included in the nomogram for prediction of subsequent first-cycle live births in patients diagnosed with RIF. Analysis of the area under the receiver-operating characteristic curve, calibration plots, and decision curve analysis showed that our predictive model for live births had excellent performance.
We have developed and validated a novel predictive model that estimates a woman's chances of having a live birth after a diagnosis of RIF and provides clinicians with a personalized clinical decision-making tool.
反复着床失败(RIF)患者在多次接受高质量胚胎移植治疗后仍无法妊娠和活产,这已被认为是人工生殖技术成功应用的主要障碍。本研究旨在建立和验证一种预测 RIF 患者首次周期活产的列线图,以指导临床实践。
本研究纳入了 2017 年 1 月至 2020 年 12 月在新疆医科大学第一附属医院生殖中心首次诊断为 RIF 并接受体外受精/卵胞浆内单精子注射治疗的 538 例患者。患者按 7:3 的比例随机分为训练队列(n=408)和验证队列(n=175)。基于单因素和多因素逻辑回归分析的结果,使用训练集构建列线图模型,并在验证集中进行验证。
年龄、体重指数、RIF 持续时间、子宫内膜厚度、移植胚胎类型和既往生化妊娠次数均纳入 RIF 患者首次周期活产预测的列线图中。受试者工作特征曲线下面积、校准图和决策曲线分析表明,我们的活产预测模型具有良好的性能。
我们已经开发并验证了一种新的预测模型,该模型可以估计 RIF 诊断后女性活产的机会,并为临床医生提供个性化的临床决策工具。